Noramco Buprenorphine Hydrochloride Noramco Buprenorphine Hydrochloride

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Buprenorphine Hydrochloride on PharmaCompass.com

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • INJECTABLE;INJECTION - EQ 0.3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • IMPLANT;IMPLANTATION - EQ 80MG BASE/IMPLANT
  • FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE
  • FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE
  • FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE
  • TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • FILM;BUCCAL - EQ 0.075MG BASE
  • FILM;BUCCAL - EQ 0.15MG BASE
  • FILM;BUCCAL - EQ 0.3MG BASE
  • FILM;BUCCAL - EQ 0.45MG BASE
  • FILM;BUCCAL - EQ 0.6MG BASE
  • FILM;BUCCAL - EQ 0.75MG BASE
  • FILM;BUCCAL - EQ 0.9MG BASE
  • FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE
  • FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE
  • FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE
  • FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9901539
2032-12-21
U-1556
207932
MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQ
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9901539
2032-12-21
U-1556
207932
MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQ
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8147866
Y
2027-07-23
U-1769
207932
TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9655843
Y
2027-07-23
U-1556
207932
MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQ
7
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9655843
Y
2027-07-23
U-2017
205637
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8147866
Y
2027-07-23
U-1769
207932
TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9655843
Y
2027-07-23
U-1556
207932
MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQ
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9655843
Y
2027-07-23
U-1556
207932
MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQ
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8703177
Y
2032-08-20
205637
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9522188
Y
2035-04-24
205637
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9901539
2032-12-21
U-1556
207932
MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQ
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9655843
Y
2027-07-23
U-1556
207932
MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQ
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9655843
Y
2027-07-23
U-1556
207932
MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQ
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9655843
Y
2027-07-23
U-1556
207932
MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQ
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9655843
Y
2027-07-23
U-2017
205637
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9655843
Y
2027-07-23
U-2017
205637
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8147866
Y
2027-07-23
U-1769
207932
TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
11135216
Y
2029-08-07
U-3111
22410
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8475832
Y
2030-03-26
U-1411
22410
THIS DRUG IS ADMINISTERED BY SUBLINGUAL ROUTE TO HUMANS FOR MAINTENANCE TREATMENT OF OPIOID DEPENDENCE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8475832
Y
2030-03-26
U-1411
22410
THIS DRUG IS ADMINISTERED BY SUBLINGUAL ROUTE TO HUMANS FOR MAINTENANCE TREATMENT OF OPIOID DEPENDENCE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
8658198
Y
2027-12-03
U-1494
204242
SUBLINGUAL OR BUCCAL ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION COMPRISING BUPRENORPHINE AND NALOXONE
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
10946010
Y
2032-09-18
204242
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
9259421
Y
2032-09-18
204242
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
10946010
Y
2032-09-18
204242
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
11020388
Y
2032-09-18
U-3131
204242
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
10874661
Y
2032-09-18
204242
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
8658198
Y
2027-12-03
U-1494
204242
SUBLINGUAL OR BUCCAL ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION COMPRISING BUPRENORPHINE AND NALOXONE
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
9439900
Y
2032-09-18
204242
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
9439900
Y
2032-09-18
Y
204242
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
11020388
Y
2032-09-18
U-3131
204242
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
9259421
Y
2032-09-18
204242
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
8658198
Y
2027-12-03
U-1494
204242
SUBLINGUAL OR BUCCAL ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION COMPRISING BUPRENORPHINE AND NALOXONE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
10946010
Y
2032-09-18
204242
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
11020387
Y
2032-09-18
U-3131
204242
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
11020388
Y
2032-09-18
U-3131
204242
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
8470361
Y
2030-05-22
U-1425
204242
SUBLINGUAL ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION COMPRISING BUPRENORPHINE AND NALOXONE
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
10946010
Y
2032-09-18
204242
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
11020387
Y
2032-09-18
U-3131
204242
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
8940330
Y
2032-09-18
204242
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
11020388
Y
2032-09-18
U-3131
204242
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
8470361
Y
2030-05-22
U-1425
204242
SUBLINGUAL ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION COMPRISING BUPRENORPHINE AND NALOXONE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
8940330
Y
2032-09-18
204242
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
10946010
Y
2032-09-18
204242
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
11020387
Y
2032-09-18
U-3131
204242
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
9439900
Y
2032-09-18
204242
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
11020388
Y
2032-09-18
U-3131
204242
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
9259421
Y
2032-09-18
204242
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
8658198
Y
2027-12-03
U-1494
204242
SUBLINGUAL OR BUCCAL ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION COMPRISING BUPRENORPHINE AND NALOXONE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
8658198
Y
2027-12-03
U-1494
204242
SUBLINGUAL OR BUCCAL ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION COMPRISING BUPRENORPHINE AND NALOXONE
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Sweden
Digital Content Digital Content
URL Supplier Web Content
10946010
Y
2032-09-18
204242
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY